GlassScriptPhysician profile
Anneka Johnson
NPI 1912283078
$999.55
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.67 · 2022: $214 · 2023: $632 · 2024: $80.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $213.36 | 2021-2024 | Ozempic, Rybelsus |
| Viiv Healthcare Company | $153.35 | 2021-2023 | Cabenuva |
| Glaxosmithkline, LLC. | $106.05 | 2023 | Arexvy |
| Global Blood Therapeutics, INC. | $97.13 | 2022 | |
| Janssen Products, LP | $90.11 | 2023 | Symtuza |
| Janssen Scientific Affairs, LLC | $88.19 | 2023 | Prezista, Symtuza |
| Janssen Pharmaceuticals, INC | $67.43 | 2022 | |
| Pfizer INC. | $54.60 | 2023-2024 | |
| Exact Sciences Corporation | $46.49 | 2023-2024 | Cologuard Collection Kit |
| Novavax INC | $25.57 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Otsuka America Pharmaceutical, INC. | $23.72 | 2021 | |
| Merck Sharp & Dohme LLC | $20.67 | 2022 | |
| Lilly USA, LLC | $12.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anneka Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.